Linezolid resistant Staphylococcus haemolyticus: First case report from India

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 10, 2012, Pages 837-838

  Gupta, Varsha ^a   Garg, Shivani ^a   Jain, Ruby ^a   Garg, Sudhir ^a   Chander, Jagdish ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Drug resistance; Linezolid; Staphylococcus haemolyticus

Indexed keywords

AMOXICILLIN; CLAVULANIC ACID; CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; LINEZOLID; OXACILLIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

ABSCESS DRAINAGE; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BONE PLATE; CASE REPORT; DEVICE REMOVAL; DISK DIFFUSION; DRUG RESPONSE; FRACTURE NONUNION; HIP FRACTURE; HUMAN; INDIA; MALE; MEDICAL HISTORY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; STAPHYLOCOCCUS HAEMOLYTICUS; SURGICAL INFECTION;

ACETAMIDES; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HIP FRACTURES; HUMANS; INDIA; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OXAZOLIDINONES; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS HAEMOLYTICUS; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 84867218438     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60155-2     Document Type: Article

References (14)

1. Perry CM, Jarvis B Linezolid: a review of its use in the management of serious Gram-positive infections. Drugs 2001, 61:525-551.
2. Bozdogan, Appelbaum PC Oxazolidinones: activity, mode of action and mechanism of resistance. Int J Antimicrob Agents 2004, 23:113-119.
3. Wennersten C, Venkataraman L Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 2001, 358:207-208.
4. Kelly S, Collins J, Maguire M An outbreak of colonization with linezolid resistant Staphylococcus epidermidis in an intensive therapy unit. J Antimicrob Chemother 2008, 61:9017.
5. Trevino M, Martinez-Lamas L, Romero-Jung PA Endemic linezolid resistant Staphylococcus epidermidis in a critical care unit. Eur J Clin Microbiol Infect Dis 2009, 28:527-533.
6. Long KS, Poehlsgaard J, Kehrenberg C The cfr rRNA methyl transferase confers resistance to phenicols, lincosamides, oxazolidinones, pleuromutilins and streptogramin A antibiotics. Antimicrob Agents Chemother 2006, 50:2500-2505.
7. Mendes RE, Deshpande LM, Caseanheira M First report of cfr mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 2008, 52:2244-2246.
8. Mazzariol A, Lo Cascio G, Kocsis E, Maccacaro L, Fontana R, Cornaglia G Outbreak of linezolid-resistant Staphylococcus haemolyticus in an Italian intensive care unit. Eur J Clin Microbiol Infect Dis 2012, 4(31):523-527.
9. Peer MA, Nasir RA, Kakru DK, Fomda BA, Bashir G, Sheikh IA Sepsis due to linezolid resistant Staphylococcus cohnii and Staphylococcus kloosii: First reports of linezolid resistance in coagulase-negative Staphylococci from India. Indian J Med Microbiol 2011, 29:60-62.
10. Kalawat U, Sharma KK, Reddy S Linezolid-resistant Staphylococcus spp. at a tertiary care hospital of Andhra Pradesh. Indian J Med Microbiol 2011, 3(29):314-315.
11. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16 2006, CLSI, Wayne.
12. Goyal R, Singh NP, Kumar A, Kaur I, Singh M, Sunita N, et al. Simple and economical method for speciation and resistotyping of clinically significant coagulase negative Staphylococci. Indian J Med Microbiol 2006, 3(24):201-204.
13. Uçkay I, Harbarth S, Ferry T, Lübbeke A, Emonet S, Hoffmeyer P, et al. Meticillin resistance in orthopaedic coagulase-negative staphylococcal infections. J Hosp Infect 2011, 3(79):248-253.
14. Bongiorno D, Campanile F, Mongelli G, Baldi MT, Provenzani R, Reali S, et al. DNA methylase modifications and other linezolid resistance mutations in coagulase-negative staphylococci in Italy. J Antimicrob Chemother 2010, 11(65):2336-2340.